Tim Hames
Boards are being asked to take positions on China exposure, US political volatility and UK regulatory direction without the inside knowledge to do it well. The result is either over-cautious paralysis or strategic bets made on newspaper reading. What is missing is someone who has worked inside Westminster, Fleet Street and the City and can translate political signal into commercial decision.
Tim Hames is a UK, US and China political risk adviser and former Director General of the BVCA who helps boards read political signal as commercial intelligence.
Full Profile
Why organisations work with Tim Hames
- He has run the trade body for British private equity and venture capital, so he speaks to investors, allocators and operators in their own language, not as an outside commentator.
- His China analysis is built on close study of the Chinese Communist Party’s internal operations, which is the level boards need when sanctions, supply chain and market access decisions are on the table.
- He spent a decade as chief leader writer and assistant editor at The Times, which means he can frame a complex political argument tightly enough for a board paper or an investor letter.
- He served as the first Special Adviser to the Speaker of the House of Commons, giving him direct experience of how Westminster machinery actually moves.
- He co-wrote The Long Shot with Dame Kate Bingham, the definitive insider account of the UK Vaccine Taskforce, and a Financial Times science book of the year.
Biography highlights
- Director General of the British Private Equity and Venture Capital Association (BVCA), 2013 to 2019.
- Co-founder of Acuti Associates, a UK, US and China political and geopolitical risk advisory.
- Co-author with Dame Kate Bingham of The Long Shot: The Inside Story of the Race to Vaccinate Britain (Oneworld, 2022); Sunday Times business bestseller, FT science book of the year, Money Week politics book of the year.
- Former Assistant Editor, chief leader writer and weekly political columnist at The Times.
- First Special Adviser to the Speaker of the House of Commons, with a brief on parliamentary reform.
- Former Lecturer in Politics at Oxford University, 1989 to 1996, specialising in American and British government.
Biography
Most political risk advice on offer to boards is written by people who have only ever observed politics from outside. Hames has worked inside three of the systems that matter, Westminster, the British press, and the City, and the value comes from how he connects them. His BVCA years gave him an investor’s reflex for capital flows; his Times years taught him to write a sharp, defensible argument; his Speaker’s Office year showed him how Parliament actually decides.
That combination shapes the way he reads the UK, US and China triangle through Acuti Associates, the advisory firm he co-founded. The focus is practical: what does a Trump second term mean for trans-Atlantic deal flow, how should a board think about China exposure when the signals from Beijing are deliberately opaque, what does the UK regulatory direction look like after a change of government. The answers are not generic.
His co-authored book with Dame Kate Bingham, The Long Shot, is the inside record of the UK Vaccine Taskforce, the rare British state-led project of the last decade that actually worked. It was a Financial Times science book of the year and a Sunday Times business bestseller, and it doubles as a study in how political and commercial decision-making interact under pressure.
He continues to advise financial institutions, professional services firms and technology companies, and serves as a Senior Adviser to FTI Consulting’s strategic communications practice. The work he is asked to do is consistent: translate political signal into commercial decision, before the headlines force the issue.
Key speaking topics
- UK, US and China political risk
- Geopolitical risk for boards and investors
- US politics and the Trump factor
- Chinese Communist Party decision-making
- UK government, regulation and the post-election landscape
- Private equity and venture capital policy environment
- Lessons from the UK Vaccine Taskforce
Ideal for
- Boards and investment committees with material China, US or UK regulatory exposure
- Private equity and venture capital firms briefing LPs on political risk
- Financial services and professional services leadership teams
- CEO and CFO offsites where geopolitics is a standing agenda item
Audience outcomes
- A clearer read on what to take seriously and what to discount in current US, UK and China political coverage.
- Sharper questions to put to in-house government affairs, public policy and risk teams.
- A practical sense of how Westminster, Washington and Beijing actually decide, not how they are reported.
- A more disciplined frame for board discussions on China exposure, sanctions risk and regulatory direction.
Talks
What the change of government in Westminster means for regulation, tax and the operating environment for capital.
Key takeaways:
- Where the new policy direction is genuinely different and where the continuity is underestimated.
- The specific regulatory pressure points for financial and professional services.
- How to read the next phase of UK political risk for investment committees.
A working briefing on the internal mechanics of the Chinese Communist Party and what its decision logic means for foreign business.
Key takeaways:
- How power and information actually move inside the Party.
- What current Chinese strategic ambition looks like from the inside.
- Practical implications for boards with China exposure.
A grounded read on what Trump-era Republican politics means for business, trade and trans-Atlantic relations.
Key takeaways:
- Why the Trump phenomenon is structural, not personal.
- What a second term changes for capital, tariffs and alliances.
- How European boards should be planning, not reacting.
A direct assessment of where the US-China relationship is heading and what that means for global business.
Key takeaways:
- The flashpoints that should be on every board’s risk register.
- Where decoupling is real and where it is theatre.
- How investors and operators should think about parallel exposure.
Drawing on his work with Dame Kate Bingham on The Long Shot, an insider’s view of how states and companies should prepare for the next public health shock.
Key takeaways:
- What the UK Vaccine Taskforce actually got right.
- The political and commercial decisions that nearly went wrong.
- What a credible corporate pandemic readiness posture looks like now.